Trending...
- Five Aster Awards! Fusion Marketing Group Brings Home Big Wins in 2025!
- Various Measures Introduced to and Approved by The Chicago City Council
- GMO Miner: Creating a simple, efficient and reliable new cloud mining experience
From snacks to smoking, PreScouter identifies the categories losing ground and the ones set to surge.
CHICAGO - illiNews -- Chicago, IL — PreScouter, a Chicago-based strategy consulting firm, has released a new report that uncovers hidden opportunities in the GLP-1 era, well beyond appetite control. GLP-1 drugs like Ozempic and Wegovy are curbing more than hunger. From rewired reward pathways to shifting spend patterns, the ripple effects are already being felt across pharma, food & beverage, supplements, and wellness, opening the door to white space innovation. The report serves as a strategic playbook, spotlighting which segments are at risk and where forward-looking brands can seize the next wave of growth.
"This is more than a trend; it's a major shift in how people approach food, health, and wellness," notes Thuy Ngo, report co-author and Project Architect at PreScouter. With more than 1 in 8 adults in North America already using a GLP-1 drug—and the market projected to reach $238 billion by 2034—GLP-1 adoption is driving measurable shifts in consumer behavior. For instance, early clinical trials report alcohol use dropping by 41%, smoking rates dropping from 40% to 24%, and household spending moving away from fast food and snacks toward smaller, higher-protein grocery items. These changes are reshaping daily habits and revealing new opportunities for brands positioned to meet evolving needs.
More on illi News
"GLP-1s may be one of the most disruptive drug classes in decades. These drugs are exposing weaknesses in categories built on habitual consumption," said Dr. Gareth Armanious, report co-author and Technical Director at PreScouter. "The focus is shifting from fullness to function. Brands built solely on weight loss narratives are already losing ground, and the broader market implications are only beginning to surface."
Key report findings include:
More on illi News
The report provides a comprehensive SWOT analysis of the behavioral and therapeutic disruptions tied to GLP-1 drugs, outlining the strategic implications across industries. It highlights over a dozen product innovations that directly address shifting needs in food, beverage, supplements, and digital health. Additionally, the report maps opportunities for healthcare, retail, and insurance sectors responding to the GLP-1 shift.
Link to full report: Beyond Appetite: Uncovering Hidden Opportunities in the GLP-1 Era (https://www.prescouter.com/inquiry/beyond-appetite-uncovering-hidden-opportunities-in-the-glp-1-era/#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjUxMjI2IiwidG9nZ2xlIjpmYWxzZX0%3D)
Media contact:
Mariam Jomha
872-222-9225
mjomha@prescouter.com
"This is more than a trend; it's a major shift in how people approach food, health, and wellness," notes Thuy Ngo, report co-author and Project Architect at PreScouter. With more than 1 in 8 adults in North America already using a GLP-1 drug—and the market projected to reach $238 billion by 2034—GLP-1 adoption is driving measurable shifts in consumer behavior. For instance, early clinical trials report alcohol use dropping by 41%, smoking rates dropping from 40% to 24%, and household spending moving away from fast food and snacks toward smaller, higher-protein grocery items. These changes are reshaping daily habits and revealing new opportunities for brands positioned to meet evolving needs.
More on illi News
- Lottery.com Inc. Secures $300 Million in Growth Capital, Confirms Nasdaq Compliance & Acquires UAE Sports Incubator Amid High-Profile Brand Exposure
- $750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
- NUFABRX awarded Therapeutic Compression agreement with Premier, Inc
- Luxurious Estate in Keenes Pointe Hits the Market at $2.9 Million
- Digi 995: Void Run Now Available on iOS – Action-Packed Game Tied to Second Book in Sci-Fi Series
"GLP-1s may be one of the most disruptive drug classes in decades. These drugs are exposing weaknesses in categories built on habitual consumption," said Dr. Gareth Armanious, report co-author and Technical Director at PreScouter. "The focus is shifting from fullness to function. Brands built solely on weight loss narratives are already losing ground, and the broader market implications are only beginning to surface."
Key report findings include:
- Key findings from the report include:
- Reduced alcohol and nicotine use, signaling disruption in vice-driven markets
- Lowered demand for processed snacks and sugary drinks
- Increased interest in high-protein, nutrient-dense products
- Growing emphasis on resistance training and bone health
- Rising need for behavioral and nutritional support during treatment
More on illi News
- CredHub and ManageAmerica Partner to Empower Residents Through Seamless Rent Reporting Integration
- TKSoftware Inc. Unveils ICONIC Pro: The All‑In‑One Medical Billing & Clearinghouse Solution
- Mindful Things LLC Launches AC Saver™ — A New Add-On That Cuts Cooling Bills by Up to 22%
- Baker Rights and Coercive Psychiatry: The Citizens Commission on Human Rights of Florida Hosts Monthly Mental Health Law and Human Rights Seminars
- Venardi Zurada LLP Offers Legal Support to Families After Deadly Lake Tahoe Boat Capsizing
The report provides a comprehensive SWOT analysis of the behavioral and therapeutic disruptions tied to GLP-1 drugs, outlining the strategic implications across industries. It highlights over a dozen product innovations that directly address shifting needs in food, beverage, supplements, and digital health. Additionally, the report maps opportunities for healthcare, retail, and insurance sectors responding to the GLP-1 shift.
Link to full report: Beyond Appetite: Uncovering Hidden Opportunities in the GLP-1 Era (https://www.prescouter.com/inquiry/beyond-appetite-uncovering-hidden-opportunities-in-the-glp-1-era/#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjUxMjI2IiwidG9nZ2xlIjpmYWxzZX0%3D)
Media contact:
Mariam Jomha
872-222-9225
mjomha@prescouter.com
Source: Prescouter
0 Comments
Latest on illi News
- New Frontier Aerospace Successfully Tests Its Revolutionary Mjölnir Rocket Engine
- Profiting from Elder Harm: The Push to End Psychiatric Drugging in Nursing Homes
- Coalfire Sets the Bar for Responsible AI, Unveiling Industry's First ISO 42001 Certification and Comprehensive Model Testing Program
- LET Mining launches zero-cost cloud mining, daily rewards + referral double benefits
- Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes
- Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy
- CagriSema Demonstrates Significant Weight Loss in Adults with Obesity
- Veteran-Owned Small Business Trapped in Amazon Seller Catch-22 Over Fraudulent FBA Partner
- Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes
- Norman Bolden to Debut "Norman's Bistro on the Lake" Rainbow Beach - Ribbon Cutting Ceremony Today
- Red Carpet Screening of "Ghosted" Featuring Landon Brittain at the Samuel Goldwyn Theatre
- Stem Cell-Derived Islet Therapies Shown to Reduce the Need for Injectable Insulin
- Sploot Veterinary Care Brings Modern Pet Care to Forest Park with New Clinic Opening June 23, 2025
- Anti-war groups protest vs US-NATO actions in Gaza, Iran, the Global South
- Dr. Jacqueline West Honored as Best Dentist in JAX by Folio Weekly
- Naperville Police Investigate Fatal Traffic Crash at Chicago Avenue and Naper Boulevard
- The American Diabetes Association Demonstrates Its Commitment to Curbing the Obesity Epidemic with Obesity Standards of Care
- Exciting News: Pivotal Health Solutions Acquires Revolutionary Portable Parallel Bars
- Miboxer Achieved New Goal in GILE 2025
- Jeopardy!'s Ken Jennings Headlines National Mensa Event